Status:
COMPLETED
Beta-CIT-SPECT and Neurophysiology in Depression
Lead Sponsor:
Ludwig-Maximilians - University of Munich
Collaborating Sponsors:
H. Lundbeck A/S
Conditions:
Depression
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Aim of this project is to investigate the effects of escitalopram on monoamine transporter (SERT, DAT) availabilities as assessed by b-CIT and SPECT, and on neurophysiological parameters such as the l...
Eligibility Criteria
Inclusion
- Psychiatric in or outpatients with acute depressive episode
- Indication for pharmacological treatment
Exclusion
- Acute suicidality
- Neurological or severe somatic disorders
- Occupational exposition to radiation \>15 mSv per year
- Women during pregnancy or lactation
Key Trial Info
Start Date :
June 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2009
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00145132
Start Date
June 1 2005
End Date
December 1 2009
Last Update
June 2 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Depts. of Psychiatry and Nuclear Medicine, Ludwig-Maximilians-University of Munich
Munich, Germany, D-80336